Strategic Growth Focus on next-generation enVVe System development and upcoming pivotal trial data to align sales outreach with product roadmap, target hospitals and vascular centers investing in advanced venous treatment solutions.

Clinical Evidence Highlight interim and one-year follow-up data from VenoValve trials and upcoming SVS and American Venous Forum presentations to support value propositions around improved outcomes and potential market adoption.

Investor & Executives Engage with IR and C-suite stakeholders through investor webinars and corporate connect events to time outreach with funding milestones, financial updates, and strategic partnerships.

Regulatory & Reimbursement Position conversations around bioprosthetic venous solutions to address payor coverage considerations, potential cost-savings from reduced reinterventions, and pathway to reimbursement in U.S. markets.

Market Positioning Leverage small company agility with prospect targeting toward mid-to-large vascular centers and specialty clinics, contrasting with larger rivals, to capture demand for innovative deep venous disease therapies.